______________________________________________________________________________________________________________________________________________________________________________________________________
Haasbach E, Droebner K, Vogel AB, Planz O. Low-Dose Interferon Type I Treatment Is Effective Against H5N1 and Swine-Origin H1N1 Influenza A Viruses In Vitro and In Vivo. J Interferon Cytokine Res. 2011 Feb 16. [Epub ahead of print]
Skarlas T, Zevgiti S, Droebner K, Panou-Pomonis E, Planz O, Sakarellos-Daitsiotis M. Influenza virus H5N1 hemagglutinin (HA) T-cell epitope conjugates: design, synthesis and immunogenicity. J Pept Sci. 2011 17(3):226-32.
Muhammad S, Haasbach E, Kotchourko M, Strigli A, Krenz A, Ridder DA, Vogel AB, Marti HH, Al-Abed Y, Planz O, Schwaninger M. Influenza virus infection aggravates stroke outcome. Stroke. 2011 42(3):783-91.
Sipo I, Knauf M, Fechner H, Poller W, Planz O, Kurth R, Norley S. Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). Vaccine. 2011 29(8):1690-9.
Vogel AB, Haasbach E, Reiling SJ, Droebner K, Klingel K, Planz O. Highly pathogenic influenza virus infection of the thymus interferes with T lymphocyte development. J Immunol. 2010 185(8):4824-34.
Droebner K, Klein B, Paxian S, Schmid R, Stitz L, Planz O. The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection. Viral Immunol. 2010 23(3):295-308.
Ma W, Brenner D, Wang Z, Dauber B, Ehrhardt C, Högner K, Herold S, Ludwig S, Wolff T, Yu K, Richt JA, Planz O, Pleschka S. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol. 2010 84(4):2122-33.
Gabriel G, Klingel K, Planz O, Bier K, Herwig A, Sauter M, Klenk HD. Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus. Am J Pathol. 2009 175(3):1178-86.
Planz O, Pleschka S, Wolff T. Borna disease virus: a unique pathogen and its interaction with intracellular signalling pathways. Cell Microbiol. 2009 11(6):872-9.
Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, Büttner M, Planz O. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain. Vaccine. 2008 26(52):6965-74.
Droebner K, Reiling SJ, Planz O. Role of hypercytokinemia in NF-kappaB p50-deficient mice after H5N1 influenza A virus infection. J Virol. 2008 82(22):11461-6.
Ludwig S, Planz O. Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy. Biol Chem. 2008 389(10):1307-12.
Bourteele S, Oesterle K, Weinzierl AO, Paxian S, Riemann M, Schmid RM, Planz O. Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell Microbiol. 2007 9(9):2202-17.
Droebner K, Ehrhardt C, Poetter A, Ludwig S, Planz O. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 2007 76(1):1-10
Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, Poetter A, Dreschers S, Schmolke M, Planz O, Ludwig S. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res. 2007 76(1):38-47.
Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, Ludwig S. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.
Cell Microbiol. 2007 9(7):1683-94.
Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol. 2007 81(7):3058-67.